These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1198435)

  • 21. Coagulant and anticoagulant actions of Australian snake venoms.
    Marshall LR; Herrmann RP
    Thromb Haemost; 1983 Oct; 50(3):707-11. PubMed ID: 6648891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of twig snake (Thelotornis capensis) envenomation.
    Atkinson PM; Bradlow BA; White JA; Greig HB; Gaillard MC
    S Afr Med J; 1980 Dec; 58(25):1007-11. PubMed ID: 7444704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clot-inducing substances present in snake venoms with particular reference to Echis carinatus.
    Denson KW
    Thromb Res; 1976 Mar; 8(3):351-60. PubMed ID: 1265707
    [No Abstract]   [Full Text] [Related]  

  • 24. Gaboon viper venom--a comparative study of the coagulant, proteolytic and toxic properties of four commercial dried preparations and freshly collected venom.
    Marsh N
    Toxicon; 1975 Jun; 13(3):171-5. PubMed ID: 1145641
    [No Abstract]   [Full Text] [Related]  

  • 25. Bothrops jararaca fibrinogen and its resistance to hydrolysis evoked by snake venoms.
    Vieira CO; Tanaka AS; Sano-Martins IS; Morais KB; Santoro ML; Tanaka-Azevedo AM
    Comp Biochem Physiol B Biochem Mol Biol; 2008 Dec; 151(4):428-32. PubMed ID: 18805500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels.
    Capecchi M; Scalambrino E; Griffini S; Grovetti E; Clerici M; Merati G; Chantarangkul V; Cugno M; Peyvandi F; Tripodi A
    Int J Lab Hematol; 2021 Oct; 43(5):e248-e251. PubMed ID: 33433957
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.
    Isbister GK; O'Leary MA; Schneider JJ; Brown SG; Currie BJ;
    Toxicon; 2007 Jan; 49(1):57-67. PubMed ID: 17055016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Snake venom proteins in hemostasis: new results].
    Stocker K; Meier J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):935-53. PubMed ID: 2483713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temperature dependence of the thrombin-catalyzed proteolysis of prothrombin.
    Shi F; Winzor DJ; Jackson CM
    Biophys Chem; 2004 Jul; 110(1-2):1-13. PubMed ID: 15223139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fresh frozen plasma does not reduce in vivo thrombin formation after neonatal cardiopulmonary bypass surgery.
    Långström S; Rautiainen P; Mildh L; Peltola K; Wartiovaara-Kautto U; Heikinheimo M; Petäjä J
    Thromb Haemost; 2008 Dec; 100(6):1207-8. PubMed ID: 19132253
    [No Abstract]   [Full Text] [Related]  

  • 31. Procoagulant proteins from snake venoms.
    Kini RM; Rao VS; Joseph JS
    Haemostasis; 2001; 31(3-6):218-24. PubMed ID: 11910188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of snake venom enzymes on blood coagulation.
    Kornalík F
    Pharmacol Ther; 1985; 29(3):353-405. PubMed ID: 3915360
    [No Abstract]   [Full Text] [Related]  

  • 33. Anticoagulant action of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, in umbilical cord and adult plasma: an in vitro examination.
    Koestenberger M; Gallistl S; Cvirn G; Baier K; Leschnik B; Muntean W
    Thromb Res; 2005; 115(1-2):135-42. PubMed ID: 15567465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inventory of exogenous hemostatic factors affecting the prothrombin activating pathways. For the Registry of Exogenous Hemostatic Factors of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
    Stocker K
    Thromb Haemost; 1994 Feb; 71(2):257-60. PubMed ID: 8191409
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential action of proteases from Trimeresurus malabaricus, Naja naja and Daboia russellii venoms on hemostasis.
    Gowda CD; Nataraju A; Rajesh R; Dhananjaya BL; Sharath BK; Vishwanath BS
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):295-302. PubMed ID: 16627005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on blood coagulation in vivo.
    Ouyang C; Teng CM
    Toxicon; 1976; 14(1):49-54. PubMed ID: 1258068
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of interaction between a phosphoinositide anticoagulant and a phospholipid activator in the Stypven type conversion of prothrombin to thrombin.
    Kahn MJ; Bourgain RH
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):273-6. PubMed ID: 4296603
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of the fibrinolytic enzyme system in the haemostatic defects following snake envenomation.
    Mohamed AH; Damarawy NA
    Toxicon; 1974 Oct; 12(5):467-75. PubMed ID: 4460282
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic defibrination by Bothrops marajoensis-venom.
    Matsuda T; Hideno K; Ogawara M; Kodama N; Murakami M
    Nihon Ketsueki Gakkai Zasshi; 1975 Jun; 38(3):299-305. PubMed ID: 1243223
    [No Abstract]   [Full Text] [Related]  

  • 40. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
    Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
    Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.